Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection
This study is not yet open for participant recruitment.
Verified July 2012
by Yonsei University
Study NCT01594905 Information provided by Yonsei University
First Received on May 7, 2012. Last Updated on July 20, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Hepatitis B
Additional conditions recognized in this trial
Encephalitis, Herpes Simplex
Hepatitis
Hepatitis A
Hepatitis B
Hepatitis B, Chronic
Hepatitis, Chronic
Virus Diseases
More general conditions related to this trial
Central Nervous System Diseases
Central Nervous System Infections
Central Nervous System Viral Diseases
Digestive System Diseases
DNA Virus Infections
Encephalitis
Encephalitis, Viral
Enterovirus Infections
Hepadnaviridae Infections
Hepatitis, Viral, Human
Herpesviridae Infections
Liver Diseases
Nervous System Diseases
Picornaviridae Infections
RNA Virus Infections
Interventions listed in this trial
Entecavir + Tenofovir (MDR group)
Additional drug interventions recognized in this trial
Entecavir
Tenofovir
Tenofovir disoproxil
More general drug interventions related to this trial
Anti-HIV Agents
Anti-Infective Agents
Anti-Retroviral Agents
Antiviral Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Reverse Transcriptase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Yonsei University
Bristol-Myers Squibb
Asan Medical Center
Seoul St. Mary's Hospital
Back to top of Main Content
